Literature DB >> 8701873

Intravascular imaging of serial changes of disease in saphenous vein grafts after coronary artery bypass grafting.

N Komiyama1, S Nakanishi, S Nishiyama, A Seki.   

Abstract

To clarify the structural changes of saphenous vein grafts after coronary artery bypass grafting, intravascular ultrasound and angioscopic images were obtained from 23 grafts in vivo and 5 grafts and 3 new veins in vitro; the images were compared with histologic findings. Intravascular ultrasound demonstrated a single-layered appearance at new veins and all of the angiographically normal grafts within 6 months after surgery. A triple-layered appearance that might be related to the remarkably proliferative and degenerated intima was revealed histologically at 73.3% of the normal sites of grafts between 5 and 10 years after operation. In 83.3% of the stenoses at several years after operation, angioscopy showed yellow atheromatous plaques, often with a friable surface; a heterogeneous, lucent echo pattern was revealed on intravascular ultrasound. Thus intravascular ultrasound and angioscopy may be used to identify the morphologic changes of graft at different points after implantation more precisely than conventional angiography.

Mesh:

Year:  1996        PMID: 8701873     DOI: 10.1016/s0002-8703(96)90387-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  Virtual histology by intravascular ultrasound study on degenerative aortocoronary saphenous vein grafts.

Authors:  Man-Hong Jim; William Kong-to Hau; Ryan Lap-Yan Ko; Chung-Wah Siu; Hee-Hwa Ho; Kai-Hang Yiu; Chu-Pak Lau; Wing-Hing Chow
Journal:  Heart Vessels       Date:  2010-05-29       Impact factor: 2.037

2.  A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial.

Authors:  Olivier F Bertrand; Paul Poirier; Josep Rodés-Cabau; Stéphane Rinfret; Lawrence Title; Vladimir Dzavik; Madhu Natarajan; Juan Angel; Nuria Batalla; Natalie Alméras; Olivier Costerousse; Robert De Larochellière; Louis Roy; Jean-Pierre Després
Journal:  Can J Cardiol       Date:  2009-09       Impact factor: 5.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.